| Richard Jeffrey Katz, MD | |
|
2150 Pennsylvania Ave Nw, Washington, DC 20037-3201 | |
| (202) 741-2222 | |
| (202) 741-3396 |
| Full Name | Richard Jeffrey Katz |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 52 Years |
| Location | 2150 Pennsylvania Ave Nw, Washington, District Of Columbia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295805448 | NPI | - | NPPES |
| 1295805448 | Other | NPI NUMBER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | MD 11615 (District Of Columbia) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| George Washington University Medical Faculty Associates | 4082528898 | 651 |
News Archive
Genentech, a member of the Roche Group, confirmed that following the reviews of Avastin® (bevacizumab) in metastatic breast cancer by the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA), the following regulatory announcements were made by the individual health authorities:
Keane, Inc., a U.S.-based IT services and healthcare information technology firm, today announced Keane OptimumTM 3.1 has been inspected by the Certification Commission for Health Information Technology and is certified EHR technology, IFR Stage 1 as part of the organization's Preliminary American Recovery and Reinvestment Act of 2009 certification program.
Declarative memory - memories that can be consciously recalled - is critical to everyday life. Throughout childhood and adolescence, declarative memory improves remarkably. However, until most recently, there was a critical gap in our understanding of how maturation of the prefrontal cortex drives memory development.
Xencor, Inc., a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases and cancer, today announced dosing the first patient in a Phase 2 trial of XmAb5871 in patients with IgG4-Related Disease (IgG4-RD).
› Verified 7 days ago
| Entity Name | Medical Faculty Associates, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417990581 PECOS PAC ID: 4082528898 Enrollment ID: O20031117000341 |
News Archive
Genentech, a member of the Roche Group, confirmed that following the reviews of Avastin® (bevacizumab) in metastatic breast cancer by the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA), the following regulatory announcements were made by the individual health authorities:
Keane, Inc., a U.S.-based IT services and healthcare information technology firm, today announced Keane OptimumTM 3.1 has been inspected by the Certification Commission for Health Information Technology and is certified EHR technology, IFR Stage 1 as part of the organization's Preliminary American Recovery and Reinvestment Act of 2009 certification program.
Declarative memory - memories that can be consciously recalled - is critical to everyday life. Throughout childhood and adolescence, declarative memory improves remarkably. However, until most recently, there was a critical gap in our understanding of how maturation of the prefrontal cortex drives memory development.
Xencor, Inc., a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases and cancer, today announced dosing the first patient in a Phase 2 trial of XmAb5871 in patients with IgG4-Related Disease (IgG4-RD).
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Richard Jeffrey Katz, MD 2150 Pennsylvania Ave Nw, Washington, DC 20037-3201 Ph: (202) 741-2222 | Richard Jeffrey Katz, MD 2150 Pennsylvania Ave Nw, Washington, DC 20037-3201 Ph: (202) 741-2222 |
News Archive
Genentech, a member of the Roche Group, confirmed that following the reviews of Avastin® (bevacizumab) in metastatic breast cancer by the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA), the following regulatory announcements were made by the individual health authorities:
Keane, Inc., a U.S.-based IT services and healthcare information technology firm, today announced Keane OptimumTM 3.1 has been inspected by the Certification Commission for Health Information Technology and is certified EHR technology, IFR Stage 1 as part of the organization's Preliminary American Recovery and Reinvestment Act of 2009 certification program.
Declarative memory - memories that can be consciously recalled - is critical to everyday life. Throughout childhood and adolescence, declarative memory improves remarkably. However, until most recently, there was a critical gap in our understanding of how maturation of the prefrontal cortex drives memory development.
Xencor, Inc., a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases and cancer, today announced dosing the first patient in a Phase 2 trial of XmAb5871 in patients with IgG4-Related Disease (IgG4-RD).
› Verified 7 days ago
Dr. Adefolaju Oketokun, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1629 K Street Nw, Suite 300, Washington, DC 20006 Phone: 202-636-1360 Fax: 202-636-5137 | |
Dr. Uzoamaka Theodora Nwaogwugwu, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2041 Georgia Avenue Nw, Washington, DC 20060 Phone: 202-865-7677 | |
Ms. Sruthi Nukalapati Reddy, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3800 Reservoir Road Nw, 6 Phc, Washington, DC 20007 Phone: 202-444-8123 | |
Dr. Kaustubh Subhash Yadwadkar, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3800 Reservoir Rd Nw, Cg201, Washington, DC 20007 Phone: 304-206-7595 | |
Dr. Monica Vohra, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1525 7th St Nw, Washington, DC 20001 Phone: 202-386-7020 Fax: 202-265-1970 | |
Anteneh A Tesfaye, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 110 Irving St Nw Ste C2151, Washington, DC 20010 Phone: 202-877-6998 Fax: 202-877-8909 | |
Erica Nakajima, Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 5255 Loughboro Rd Nw Fl 1, Washington, DC 20016 Phone: 202-660-6500 |